Multi-omics RNA-seq Differential Expression Analysis
Also known as: multi-omics DE analysis, integrative RNA-seq DE, multi-layer differential expression, omics-integrated transcriptomics
Multi-omics RNA-seq differential expression analysis combines transcript-level count data from RNA sequencing with one or more additional omics layers — such as proteomics, metabolomics, epigenomics, or genomic variant data — to identify genes, proteins, or metabolites that differ systematically between biological conditions. By integrating multiple molecular levels, the pipeline captures regulatory mechanisms that transcriptomics alone cannot resolve, enabling a more complete picture of the biological processes driving observed phenotypes.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
Use this pipeline when you have matched multi-omics data from the same biological samples (e.g., RNA-seq plus proteomics or metabolomics) and your question concerns how molecular regulation at multiple levels differs between two or more biological conditions (e.g., treated vs. control, diseased vs. healthy). It is particularly valuable when prior single-omics studies have produced incomplete or conflicting results, suggesting post-transcriptional or post-translational regulation. Do not apply it when only a single omics layer is available — DESeq2 or edgeR alone is then the appropriate choice. Avoid the pipeline if sample sizes are very small (fewer than 3 biological replicates per condition per layer), because both statistical testing and batch correction become unreliable. The pipeline requires bioinformatics expertise and substantial computational resources; it is not appropriate for preliminary exploratory work where a quick transcriptomic screen would suffice.
Strengths & limitations
- Captures multi-level regulatory mechanisms — transcriptional, post-transcriptional, and post-translational — that single-omics approaches miss.
- Reduces false-positive biological conclusions by requiring concordant signals across independent molecular layers before drawing mechanistic inferences.
- Well-supported by mature, widely adopted tools (DESeq2, edgeR, MOFA+, mixOmics) with extensive documentation and active communities.
- Produces pathway-level biological interpretations that are more actionable for hypothesis generation than gene lists alone.
- Scalable to large cohorts when combined with cloud or HPC computing environments.
- Requires matched samples across all omics layers, which is logistically demanding and expensive to generate.
- Each additional omics layer multiplies data volume, computational cost, and the complexity of quality control and normalisation decisions.
- Statistical power is reduced when testing across thousands of features; stringent multiple-testing correction can mask true positives if the study is underpowered.
- Integrative methods (MOFA+, mixOmics) introduce additional modelling assumptions and hyperparameters that can substantially affect results.
- Biological interpretation of cross-layer correlations is correlational, not causal; mechanistic claims require further experimental validation.
Frequently asked
Do I need the same number of samples in each omics layer?
Yes — for integration to be valid, every sample must be profiled in every omics layer. Missing data in one layer for a subset of samples either requires imputation (which introduces uncertainty) or exclusion of those samples from the integrated analysis. Plan sample collection and processing so that all layers are measured on the same biological material before beginning the experiment.
Which tool should I use for the differential expression step — DESeq2 or edgeR?
Both are appropriate for RNA-seq count data and produce comparable results on well-replicated datasets. DESeq2 is generally preferred when sample sizes are small (3–6 replicates per group) because its shrinkage estimator for fold change and dispersion is more conservative. edgeR offers more flexibility for complex experimental designs. For proteomics data modelled as continuous intensities, limma or limma-voom is the established choice.
Is a minimum sample size required?
A minimum of 3 biological replicates per condition per omics layer is an absolute floor for any statistical test; 6 or more per group is strongly recommended to achieve adequate power for detecting moderate effect sizes at FDR < 0.05. Pilot power calculations using tools such as RnaSeqSampleSize or PROPER should be performed before data collection.
What is MOFA+ and when should I use it instead of simple overlap analysis?
MOFA+ (Multi-Omics Factor Analysis v2) is a Bayesian latent-factor model that learns factors capturing shared and layer-specific variance across omics datasets simultaneously. It is more powerful than overlap analysis when the biological signal is distributed across many features rather than concentrated in a few strongly DE genes. Use MOFA+ when you want to discover global patterns of co-variation; use overlap analysis when you want a transparent, interpretable list of features consistently changed across layers.
How do I report multi-omics DE results to meet journal standards?
Report: (1) the number of biological replicates per condition per layer; (2) the normalisation and batch-correction methods applied to each layer; (3) the DE testing tool, FDR threshold, and fold-change cutoff used; (4) the integration strategy and any software versions; (5) volcano plots and heatmaps for each layer; (6) the enrichment analysis database version and statistical method. Raw count matrices and processed data should be deposited in a public repository (GEO, PRIDE, MetaboLights).
Sources
- Love, M. I., Huber, W., & Anders, S. (2014). Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biology, 15(12), 550. DOI: 10.1186/s13059-014-0550-8 ↗
- Argelaguet, R., Velten, B., Arnol, D., Dietrich, S., Zenz, T., Marioni, J. C., Buettner, F., Huber, W., & Stegle, O. (2018). Multi-Omics Factor Analysis — a framework for unsupervised integration of multi-omics data sets. Molecular Systems Biology, 14(6), e8124. DOI: 10.15252/msb.20178124 ↗
How to cite this page
ScholarGate. (2026, June 3). Multi-omics RNA-seq Differential Expression Analysis. ScholarGate. https://scholargate.app/en/bioinformatics/multi-omics-rna-seq-differential-expression
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- Gene Set Enrichment AnalysisBioinformatics↔ compare